BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

SecurityBBIO / BridgeBio Pharma, Inc.
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership217,084 shares
Latest Disclosed Value $ 16,120,582
Advisor Group Holdings, Inc. reports 13.91% decrease in ownership of BBIO / BridgeBio Pharma, Inc.

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 217,084 shares of BridgeBio Pharma, Inc. (US:BBIO) valued at $16,120,658 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 252,145 shares of BridgeBio Pharma, Inc.. This represents a change in shares of -13.91% during the quarter. The current value of the position is $14,677,049 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BRIDGEBIO PHARMA COM 10806X102 217,084 -35,061 -13.91 16,121 -16.42 0.0137
2026-02-17 2025-12-31 13F BRIDGEBIO PHARMA COM 10806X102 252,145 -7,913 -3.04 19,286 42.79 0.0282
2025-11-14 2025-09-30 13F BRIDGEBIO PHARMA COM 10806X102 260,058 255,891 6,140.89 13,507 7,445.81 0.0189
2025-09-04 2025-06-30 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 4,167 2,858 218.33 179 297.78 0.0003
2025-08-13 2025-06-30 13F BRIDGEBIO PHARMA COM 10806X102 2,122 813 76 0.0001
2025-05-12 2025-03-31 13F BRIDGEBIO PHARMA COM 10806X102 1,309 -1,921 -59.47 45 -47.67 0.0001
2025-06-06 2024-12-31 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 3,230 -15,514 -82.77 86 -81.97 0.0002
2025-02-07 2024-12-31 13F BRIDGEBIO PHARMA COM 10806X102 18,815 71 481 0.0012
2024-11-13 2024-09-30 13F BRIDGEBIO PHARMA COM 10806X102 18,744 -1,044 -5.28 477 -4.79 0.0011
2024-08-13 2024-06-30 13F BRIDGEBIO PHARMA COM 10806X102 19,788 1,918 10.73 501 -9.24 0.0012
2024-05-10 2024-03-31 13F BRIDGEBIO PHARMA COM 10806X102 17,870 2,024 12.77 552 -13.62 0.0012
2024-02-12 2023-12-31 13F BRIDGEBIO PHARMA COM 10806X102 15,846 13,489 572.30 639 930.65 0.0011
2023-11-13 2023-09-30 13F BRIDGEBIO PHARMA COM 10806X102 2,357 134 6.03 62 63.16 0.0001
2023-08-21 2023-06-30 13F/A-1 BRIDGEBIO PHARMA COM 10806X102 2,223 178 8.70 38 15.15 0.0001
2023-08-10 2023-06-30 13F BRIDGEBIO PHARMA COM 10806X102 2,223 178 38 0.0000
2023-05-12 2023-03-31 13F BRIDGEBIO PHARMA COM 10806X102 2,045 235 12.98 34 153.85 0.0001
2023-02-10 2022-12-31 13F BRIDGEBIO PHARMA COM 10806X102 1,810 -45 -2.43 13 -27.78 0.0000
2022-11-14 2022-09-30 13F BRIDGEBIO PHARMA COM 10806X102 1,855 -86 -4.43 18 0.00 0.0000
2022-08-10 2022-06-30 13F BRIDGEBIO PHARMA COM 10806X102 1,941 132 7.30 18 0.00 0.0000
2022-05-04 2022-03-31 13F BRIDGEBIO PHARMA COM 10806X102 1,809 83 4.81 18 -35.71 0.0000
2022-02-03 2021-12-31 13F BRIDGEBIO PHARMA COM 10806X102 1,726 -281 -14.00 28 -70.21 0.0001
2021-11-05 2021-09-30 13F BRIDGEBIO PHARMA COM 10806X102 2,007 0 0.00 94 -22.95 0.0002
2021-08-02 2021-06-30 13F BRIDGEBIO PHARMA COM 10806X102 2,007 341 20.47 122 19.61 0.0003
2021-05-13 2021-03-31 13F BRIDGEBIO PHARMA COM 10806X102 1,666 -122 -6.82 102 -19.69 0.0002
2021-02-10 2020-12-31 13F BRIDGEBIO PHARMA COM 10806X102 1,788 483 37.01 127 159.18 0.0003
2020-11-12 2020-09-30 13F BRIDGEBIO PHARMA COM 10806X102 1,305 0 0.00 49 13.95 0.0001
2020-08-14 2020-06-30 13F BRIDGEBIO PHARMA COM 10806X102 1,305 475 57.23 43 79.17 0.0001
2020-05-18 2020-03-31 13F BRIDGEBIO PHARMA COM 10806X102 830 830 24 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.